Elimination of anti-Gal B cells by α-gal ricin

Transplantation

Volumn 73, Issue 12, 2002, Pages 1859-1868

  Tanemura, Masahiro ^a   Ogawa, Haruko ^a   Yin, Deng Ping ^a   Chen, Zhao Chun ^a   DiSesa, Verdi J ^a   Galili, Uri ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; IMMUNOGLOBULIN G; OROSOMUCOID; RICIN A;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; DRUG ELIMINATION; GENE TARGETING; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; MOLECULAR INTERACTION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECIPIENT; SWINE; XENOGRAFT;

EID: 0037182919     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206270-00002     Document Type: Article

References (33)

1. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans
2. Identification of carbohydrate structures which bind human anti-porcine antibodies: Implications for discordant grafting in man
3. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes
4. Cardiac xenografts between primate species provide evidence of the α-galactosyl determinant in hyperacute rejection
5. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters
6. Induced antibody response in xenograft recipients
7. Differential immune response to α-gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation
8. Oocyte Gal α1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse
9. The α-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation
10. Differential expression of α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) on pig and mouse organs
11. One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody
12. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora
13. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism
14. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Galα1,3Gal epitopes in α1,3-galactosyltransferase-deficient mice
15. Redesigning natures poisons to create anti-tumor reagents
16. Immunotoxins: An update
17. Anti-tumor activity of Fab and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: Effect on tumor cells in extranodal sites
18. Effects of specific anti-B and/or antiplasma cell immunotherapy on antibody production in baboons depletion of CD20- and CD22-positive B cells does not result in significantly decreased production anti-αGal antibody
19. Synthesis of α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) on human tumor cells by recombinant al,3 galactosyltransferase produced in Pichic pastoris
20. Defining the minimal size of catalytically active primate, α1,3 galactosyltransferase: Structure function studies on the recombinant truncated enzyme
21. A sensitive assay for measuring α-gal epitope expression on cells by a monoclonal anti-Gal antibody
22. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Galal,3Gal-mediated graft rejection
23. Identification of B cells with receptors for α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) in xenograft recipients
24. Porcine cartilage transplants in cynomolgus monkey: III. Transplantation of α-galactosidase treated porcine cartilage
25. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides
26. The differential expression of epitopes Galα1-3Galβ1-4GlcNAc-R residues on mammalian secreted N-glycosylated glycoproteins
27. Man, apes and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells
28. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption
29. The role of anti-Galal-3Gal antibodies in acute vascular rejection and accommodation of xenografts
30. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons
31. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Galal,3Gal-mediated graft rejection
32. Inhibition of xenoreactive natural antibody production by retroviral gene therapy
33. Engagement of antigen-receptor on immature murine B lymphocytes results in cell death by apoptosis